IL13RA2 and head and neck squamous cell carcinoma: The outcomes of these investigations have demonstrated significant cytotoxic effects on cancer cell populations in GBM, renal cell carcinoma (RCC), and head and neck squamous cell carcinoma (HNSCC), highlighting the potential of this targeted approach in the treatment of cancers expressing IL-13Rα2 [108].